USPTO serial 87936976
ADVANSE
Reviewed by CopyMark Law Group
Status 605
- Filing date
- Status date
- Registration date
- —
- Examiner
- MAIHOS, JESSIE ANDREA
- Law office
- PETITIONS OFFICE
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with ADVANSE?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Julie Beth Albert
JULIE BETH ALBERT BAKER BOTTS L.L.P.30 ROCKEFELLER PLAZA44TH FLOORNEW YORK, NY 10112-4498Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | A full line of pharmaceuticals for the treatment of depression, hypertension, malaria, metastatic prostate cancer, benign prostatic hyperplasia, partial seizures in adults with epilepsy, attention deficit hyperactivity disorder (ADHD), heart failure in adults, heart failure in pediatric patients, atrial fibrillation in adults, edema associated with congestive heart failure, edema associated with cirrhosis of the liver, edema associated with nephrotic syndrome, steroid-induced edema, idiopathic edema, edema due to secondary hyperaldosteronism, acute enterocolitis, duodenal ulcer, and irritable bowel syndrome being irritable colon, spastic colon, mucous colitis; anti-inflammatory medicines, immunosuppressive agents, namely, corticosteroids; pharmaceutical preparations for the treatment of cancers and abnormal cells | ABANDONED | — |
| 010 | Medical devices, namely, lasers and fibre-optic wires and cables for use in photodynamic therapy with the administration of a photosensitizing agent for the treatment of cancer | ABANDONED | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Concordia International RX (UK) Limited
- Other trademarks owned by Concordia International RX (UK) Limited
- Other trademarks in Class 005
- Other trademarks in Class 010
- Similar marks named ADVANSE
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jan 23, 2019 | MAB5 | ABANDONMENT NOTICE E-MAILED - AFTER PUBLICATION | — |
| Jan 23, 2019 | ABN5 | ABANDONMENT - AFTER PUBLICATION | — |
| Jan 22, 2019 | ETOF | EXTENSION OF TIME TO OPPOSE RECEIVED | — |
| Jan 22, 2019 | EXAR | TEAS EXPRESS ABANDONMENT RECEIVED | — |
| Dec 25, 2018 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Dec 25, 2018 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Dec 5, 2018 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Nov 16, 2018 | ALIE | ASSIGNED TO LIE | — |
| Oct 31, 2018 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Oct 31, 2018 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Oct 31, 2018 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Oct 31, 2018 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Oct 31, 2018 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Oct 26, 2018 | ZZZX | PREVIOUS ALLOWANCE COUNT WITHDRAWN | — |
| Oct 2, 2018 | PBCR | WITHDRAWN FROM PUB - OG REVIEW QUERY | — |
| Sep 15, 2018 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Sep 15, 2018 | DOCK | ASSIGNED TO EXAMINER | — |
| Jun 3, 2018 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| May 29, 2018 | NWAP | NEW APPLICATION ENTERED | — |